OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00278357

Hubei Kailong Chemical Group Co Ltd

Commodity ChemicalsVerified

Hubei Kailong Chemical Group Co Ltd has a debt-to-equity ratio of 1.1, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.01, suggesting that it has just enough current assets to cover its current liabilities. The company's free cash flow of 314.7 million CNY indicates that it generates positive cash from operations after capital expenditures, which could be used for debt reduction or shareholder returns. In terms of profitability, the company's return on equity (ROE) is 5.41%, which is below the typical benchmark for strong performance in the chemical industry. Its return on assets (ROA) is 1.66%, also below the median for the industry, indicating that the company is not efficiently utilizing its assets to generate profits. The operating margin is 9.9%, calculated as operating income of 350.6 million CNY divided by revenue of 3.544 billion CNY, which is in line with the industry average. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to regional economic or regulatory risks. The company's revenue concentration in a single segment and region increases its vulnerability to market-specific downturns. The company's growth trajectory is modest, with no specific revenue growth rate provided in the available data. However, the company's operating cash flow of 516.1 million CNY and free cash flow of 314.7 million CNY suggest that it has the capacity to fund operations and potentially invest in growth initiatives. The company's capital expenditures of -141.99 million CNY indicate that it is not currently investing in new projects or expanding its operations. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to raise additional capital or refinance its debt in the near term. The company's dilution risk is low, as there is no indication of recent or planned share issuances that could dilute existing shareholders. Recent events, as disclosed in the company's financial statements, include a last actual EPS of 0.14 CNY, as reported by analysts. There are no specific recent filings or transcripts provided in the available data that indicate significant changes in the company's operations or strategy.

30-day price · 002783-0.55 (-6.0%)
Low$8.60High$9.85Close$8.65As of15 May, 00:00 UTC
Profile
CompanyHubei Kailong Chemical Group Co Ltd
Ticker002783.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Hubei Kailong Chemical Group Co Ltd is a Chinese chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a confidence level of 0.92 based on verified market data.

Hubei Kailong Chemical Group Co Ltd has a debt-to-equity ratio of 1.1, indicating a moderate reliance on debt financing. The company's liquidity is assessed as medium, with a current ratio of 1.01, suggesting that it has just enough current assets to cover its current liabilities. The company's free cash flow of 314.7 million CNY indicates that it generates positive cash from operations after capital expenditures, which could be used for debt reduction or shareholder returns. In terms of profitability, the company's return on equity (ROE) is 5.41%, which is below the typical benchmark for strong performance in the chemical industry. Its return on assets (ROA) is 1.66%, also below the median for the industry, indicating that the company is not efficiently utilizing its assets to generate profits. The operating margin is 9.9%, calculated as operating income of 350.6 million CNY divided by revenue of 3.544 billion CNY, which is in line with the industry average. The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no geographic diversification provided in the available data. This lack of diversification could expose the company to regional economic or regulatory risks. The company's revenue concentration in a single segment and region increases its vulnerability to market-specific downturns. The company's growth trajectory is modest, with no specific revenue growth rate provided in the available data. However, the company's operating cash flow of 516.1 million CNY and free cash flow of 314.7 million CNY suggest that it has the capacity to fund operations and potentially invest in growth initiatives. The company's capital expenditures of -141.99 million CNY indicate that it is not currently investing in new projects or expanding its operations. The company's risk profile is characterized by a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may need to raise additional capital or refinance its debt in the near term. The company's dilution risk is low, as there is no indication of recent or planned share issuances that could dilute existing shareholders. Recent events, as disclosed in the company's financial statements, include a last actual EPS of 0.14 CNY, as reported by analysts. There are no specific recent filings or transcripts provided in the available data that indicate significant changes in the company's operations or strategy.
Key takeaways
  • Hubei Kailong Chemical Group Co Ltd has a moderate debt load with a debt-to-equity ratio of 1.1.
  • The company's ROE of 5.41% and ROA of 1.66% indicate below-average profitability for the chemical industry.
  • The company's revenue is concentrated in a single business segment, increasing its exposure to market-specific risks.
  • The company's liquidity is assessed as medium, with a current ratio of 1.01.
  • The company's free cash flow of 314.7 million CNY provides some flexibility for debt reduction or shareholder returns.
  • The company's dilution risk is low, with no recent or planned share issuances.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$3.54B
Gross profit$1.06B
Operating income$350.6M
Net income$142.4M
R&D
SG&A
D&A
SBC
Operating cash flow$516.1M
CapEx-$142.0M
Free cash flow$314.7M
Total assets$8.58B
Total liabilities$5.95B
Total equity$2.63B
Cash & equivalents
Long-term debt$2.89B
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY0$3.54B$350.6M$142.4M$314.7M
FY-1$3.69B$344.5M$148.2M$152.0M
FY-2$3.78B$324.8M$175.4M-$59.1M
FY-3$3.41B$181.4M$133.4M$116.7M
FY-4$2.76B-$479.4M-$394.7M-$602.2M
PeriodGross %Op %Net %FCF %
FY0
FY-1
FY-2
FY-3
FY-4
PeriodAssetsEquityCashDebt
FY0$8.58B$2.63B
FY-1$8.06B$2.53B
FY-2$7.46B$1.57B
FY-3$7.46B$1.43B
FY-4$6.82B$1.30B
PeriodOCFCapExFCFSBC
FY0$516.1M-$142.0M$314.7M
FY-1$402.1M-$209.0M$152.0M
FY-2$488.9M-$484.4M-$59.1M
FY-3$262.7M-$234.5M$116.7M
FY-4$9.7M-$258.7M-$602.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ0$715.3M$37.1M$9.6M
FQ-1$975.3M$48.8M$7.3M
FQ-2$827.9M$82.4M$28.2M
FQ-3$976.9M$143.2M$70.9M
FQ-4$763.9M$81.0M$36.0M
FQ-5$1.12B$71.8M$36.2M
FQ-6$930.8M$92.5M$46.9M
FQ-7$963.7M$89.2M$38.3M
PeriodGross %Op %Net %FCF %
FQ0
FQ-1
FQ-2
FQ-3
FQ-4
FQ-5
FQ-6
FQ-7
PeriodAssetsEquityCashDebt
FQ0$8.25B$2.66B$750.8M
FQ-1$8.58B$2.63B
FQ-2$8.20B$2.62B$718.0M
FQ-3$8.20B$2.59B
FQ-4$8.28B$2.56B$862.3M
FQ-5$8.06B$2.53B
FQ-6$8.32B$2.48B$890.4M
FQ-7$8.12B$2.42B
PeriodOCFCapExFCFSBC
FQ0-$46.1M-$34.6M
FQ-1$516.1M-$142.0M
FQ-2$277.6M-$110.9M
FQ-3$278.3M-$96.7M
FQ-4$52.2M-$72.7M
FQ-5$402.1M-$209.0M
FQ-6$209.1M-$154.6M
FQ-7$236.0M-$87.1M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.63B
Net cash-$2.89B
Current ratio1.0
Debt/Equity1.1
ROA1.7%
ROE5.4%
Cash conversion3.6%
CapEx/Revenue-4.0%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002783Activity
Op margin9.9%0.4% medp25 -8.0% · p75 16.0%above median
Net margin4.0%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin29.8%20.8% medp25 14.9% · p75 24.0%top quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-4.0%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity110.0%59.0% medp25 54.9% · p75 72.9%top quartile
Observations
IR observations
Last actual EPS0.14 CNY
Source: analysis-pipeline (hybrid)Generated: 2026-05-18 00:06 UTCJob: f88fe731